6 results
6-K
CNTB
Connect Biopharma Holdings Ltd
30 Dec 22
Connect Biopharma Provides Business and Clinical Development Program Update
8:00am
quarter of 2023 to discuss the Company’s CBP-201 data package.
The information in the paragraphs above under “Information Contained in this Report on Form
6-K
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
30 Dec 22
Connect Biopharma Provides Business and Clinical Development Program Update
8:00am
quarter of 2023 to discuss the Company’s CBP-201 data package for a potential NDA filing as early as 2024 and potential approval in China as early
20-F
2021 FY
CNTB
Connect Biopharma Holdings Ltd
31 Mar 22
Annual report (foreign)
4:33pm
Compensation Program is intended to provide a total compensation package that enables us to attract and retain qualified and experienced individuals
DRSLTR
cqmr14jw5 6gqf
26 Jan 21
Correspondence regarding draft registration statement
12:00am
- Prev
- 1
- Next